<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2024_1_163</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>TOLL-ПОДОБНЫЕ РЕЦЕПТОРЫ И БРОНХИАЛЬНАЯ АСТМА: ЧАСТЬ 1</article-title><trans-title-group xml:lang="en"><trans-title>TOLL-LIKE RECEPTORS AND BRONCHIAL ASTHMA: PART 1</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минеева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mineeva</surname><given-names>А. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>644099, г. Омск, ул. Ленина, 12</p></bio><bio xml:lang="en"><p>Omsk, 12 Lenin Str., 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>644099, г. Омск, ул. Ленина, 12</p></bio><bio xml:lang="en"><p>Omsk, 12 Lenin Str., 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонов</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Antonov</surname><given-names>О. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>644099, г. Омск, ул. Ленина, 12</p></bio><bio xml:lang="en"><p>Omsk, 12 Lenin Str., 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Омский государственный медицинский университет» Министерства здравоохранения&#13;
Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>163</fpage><lpage>169</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Минеева А.А., Макарова Л.В., Антонов О.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Минеева А.А., Макарова Л.В., Антонов О.В.</copyright-holder><copyright-holder xml:lang="en">Mineeva А.А., Makarova L.V., Antonov О.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/19">https://www.zabmedvestnik.ru/jour/article/view/19</self-uri><abstract><p>Бронхиальная астма – хроническое заболевание дыхательных путей, которое формируется при действии эндогенных факторов и влиянии окружающей среды. При этом, Т-хелперы второго типа играют основную роль в развитии бронхиальной астмы, вызывая гиперреактивность и воспаление дыхательных путей. Однако данных о том, что бронхиальная астма в большинстве случаев является аллергическим, эозинофильным, опосредованным Т-хелперами второго типа заболеванием, оказывается недостаточно для установления полного контроля над течением заболевания. Вероятно, это объясняется тем, что в патогенезе астмы немаловажную роль играют эндогенные факторы, знание о которых на данный момент ограничено. Toll-подобные рецепторы являются установленным элементом развития бронхиальной астмы. Их недостаточную функцию или, наоборот, запуск чрезмерного иммунного ответа связывают с инициацией заболевания или его обострениями. Расширение представления о Toll-рецепторах ведет не только к более детальному пониманию патогенеза бронхиальной астмы, но и применению этих знаний в практической деятельности.</p></abstract><trans-abstract xml:lang="en"><p>Bronchial asthma is a chronic disease of the respiratory tract, which is formed by the action of endogenous factors and environmental influences. At the same time, T-helpers of the second type play a major role in the development of bronchial asthma, causing hyperreactivity and inflammation of the respiratory tract. However, the data that bronchial asthma in most cases is an allergic, eosinophilic, T-helper-mediated disease of the second type is insufficient to establish complete control over the course of disease. This is probably due to the fact that endogenous factors play an important role in the pathogenesis of asthma, knowledge of which is currently limited. Toll-like receptors are an established element of the development of bronchial asthma. Their insufficient function or, conversely, the launch of an excessive immune response is associated with the initiation of the disease or its exacerbations. Expanding the understanding of Toll-like receptors leads not only to a more detailed understanding of the pathogenesis of bronchial asthma, but also to the application of this knowledge in practice.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>бронхиальная астма</kwd><kwd>Toll-подобные рецепторы</kwd><kwd>Т-хелперы</kwd><kwd>патогенез</kwd><kwd>иммунный ответ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bronchial asthma</kwd><kwd>Toll-like receptors</kwd><kwd>T-helpers</kwd><kwd>pathogenesis</kwd><kwd>immune response</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют об отсутствии внешнего финансирования при проведении исследования.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global Initiative for Asthma. Global strategy for asthma management and prevention. Apdate 2023 [cited 2024 Mar 18]. Available from: https://www.ginasthma.org/reports.</mixed-citation><mixed-citation xml:lang="en">Global Initiative for Asthma. Global strategy for asthma management and prevention. Apdate 2023 [cited 2024 Mar 18]. Available from: https://www.ginasthma.org/reports.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Супрун Е.Н., Наговицына Е.Б., Кудерова Н.И., Супрун С.В., Лебедько О.А. Некоторые ассоциации полиморфизмов генов Toll-подобных рецепторов и их клинико-патогенетические проявления при бронхиальной астме у детей. Медицинская иммунология. 2020. 22 (5). 915-924. DOI 10.15789/1563-0625-SGO-2049.</mixed-citation><mixed-citation xml:lang="en">Suprun E.N., Nagovitsyna E.B., Kuderova N.I., Suprun S.V., Lebedko O.A. Some associations of polymorphisms of Toll-like receptor genes and their clinical and pathogenetic manifestations in bronchial asthma in children. Medical immunology. 2020. 22 (5). 915-924. DOI 10.15789/1563-0625-SGO-2049. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гималова Г.Ф., Карунас А.С., Федорова Ю.Ю., Загидуллин Ш.З., Эткина Э.И., Хуснутдинова Э.К. Ассоциация полиморфных вариантов генов Toll-подобных рецепторов TLR1 и TLR6 с развитием бронхиальной астмы. Пульмонология. 2017. 5. 607-613. DOI 10.18093/086901892017275607613.</mixed-citation><mixed-citation xml:lang="en">Himalova G.F., Karunas A.S., Fedorova Yu.Yu., Zagidullin Sh.Z., Etkina E.I., Khusnutdinova E.K. Association of polymorphic variants of Toll-like receptors TLR1 and TLR6 with the development of bronchial asthma. Pulmonology. 2017. 5. 607-613. DOI 10.18093/086901892017275607613. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Frey A., Lunding L.P., Ehlers J.C. et al. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front. Immunol. 2020. 11. 761. DOI 10.3389/fimmu.2020.00761.</mixed-citation><mixed-citation xml:lang="en">Frey A., Lunding L.P., Ehlers J.C. et al. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front. Immunol. 2020. 11. 761. DOI 10.3389/fimmu.2020.00761.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Reddel H.K., Bacharier L.B., Bateman E.D. et al. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. J. Allergy Clin. Immunol. Pract. 2022. 10 (1). 1-18. DOI 10.1016/j.jaip.2021.10.001.</mixed-citation><mixed-citation xml:lang="en">Reddel H.K., Bacharier L.B., Bateman E.D. et al. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. J. Allergy Clin. Immunol. Pract. 2022. 10 (1). 1-18. DOI 10.1016/j.jaip.2021.10.001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zakeri A, Yazdi F.G. Toll-like receptor-mediated involvement of innate immune cells in asthma disease. Biochim. Biophys. Acta. Gen. Subj. 2017. 1861 (1). 3270-3277. DOI 10.1016/j.bbagen.2016.08.009.</mixed-citation><mixed-citation xml:lang="en">Zakeri A, Yazdi F.G. Toll-like receptor-mediated involvement of innate immune cells in asthma disease. Biochim. Biophys. Acta. Gen. Subj. 2017. 1861 (1). 3270-3277. DOI 10.1016/j.bbagen.2016.08.009.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Кытикова О.Ю., Новгородцева Т.П., Денисенко Ю.К., Антонюк М.В., Гвозденко Т.А. Toll-подобные рецепторы в патофизиологии бронхиальной астмы. Пульмонология. 2021. 31 (3). 348-354. DOI 10.18093/0869-0189-2021-31-3-348-354.</mixed-citation><mixed-citation xml:lang="en">Kytikova O.Yu., Novgorodtseva T.P., Denisenko Yu.K., Antonyuk M.V., Gvozdenko T.A. Toll-like receptors in the pathophysiology of bronchial asthma. Pulmonology. 2021. 31 (3). 348-354. DOI 10.18093/0869-0189-2021-31-3-348-354. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Athari S.S., Athari S.M., Beyzay F. et al. Critical role of Toll-like receptors in pathophysiology of allergic asthma. Eur. J. Pharmacol. 2017. 808. 21-27. DOI 10.1016/j.ejphar.2016.11.047.</mixed-citation><mixed-citation xml:lang="en">Athari S.S., Athari S.M., Beyzay F. et al. Critical role of Toll-like receptors in pathophysiology of allergic asthma. Eur. J. Pharmacol. 2017. 808. 21-27. DOI 10.1016/j.ejphar.2016.11.047.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lv J., Yu Q., Lv J. et al. Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation. Eur. J. Immunol. 2018. 48 (11). 1838-1850. DOI 10.1002/eji.201847663.</mixed-citation><mixed-citation xml:lang="en">Lv J., Yu Q., Lv J. et al. Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation. Eur. J. Immunol. 2018. 48 (11). 1838-1850. DOI 10.1002/eji.201847663.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Y., Li H., Fotopoulou C. et al. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges. Front. Immunol. 2022. 13. 1049340. DOI 10.3389/fimmu.2022.1049340.</mixed-citation><mixed-citation xml:lang="en">Yang Y., Li H., Fotopoulou C. et al. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges. Front. Immunol. 2022. 13. 1049340. DOI 10.3389/fimmu.2022.1049340.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Duan T., Du Y., Xing C. et al. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Front. Immunol. 2022. 13. 812774. DOI 10.3389/fimmu.2022.812774.</mixed-citation><mixed-citation xml:lang="en">Duan T., Du Y., Xing C. et al. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Front. Immunol. 2022. 13. 812774. DOI 10.3389/fimmu.2022.812774.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kirtland M.E., Tsitoura D.C., Durham S.R., Shamji M.H. Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy. Front. Immunol. 2020. 11. 599083. DOI 10.3389/fimmu.2020.599083.</mixed-citation><mixed-citation xml:lang="en">Kirtland M.E., Tsitoura D.C., Durham S.R., Shamji M.H. Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy. Front. Immunol. 2020. 11. 599083. DOI 10.3389/fimmu.2020.599083.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Никонова А.А., Хаитов М.Р., Хаитов Р.М. Перспективы использования агонистов и антагонистов Toll-подобных рецепторов для профилактики и лечения вирусных инфекций. Медицинская иммунология. 2019. 21 (3). 397-406. DOI 10.15789/1563-0625-2019-3-397-406.</mixed-citation><mixed-citation xml:lang="en">Nikonova A.A., Khaitov M.R., Khaitov R.M. Prospects for the use of agonists and antagonists of Toll-like receptors for the prevention and treatment of viral infections. Medical immunology. 2019. 21 (3). 397-406. DOI 10.15789/1563-0625-2019-3-397-406. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Байке Е.Е., Богодухова Е.С. Роль генетического полиформизма TOLL-подобных рецепторов в развитии туберкулеза у больных ВИЧ-инфекцией. Забайкальский медицинский вестник. 2018. 2. 1-6.</mixed-citation><mixed-citation xml:lang="en">Baike E.E., Bogodukhova E.S. The role of genetic polyformism of TOLL-like receptors in the development of tuberculosis in patients with HIV infection. Zabaikalsky Medical Bulletin. 2018. 2. 1-6. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Owen A.M., Luan L., Burelbach K.R. et al. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages. Front. Immunol. 2022. 13. 1044661. DOI 10.2289/fimmu.2022.1044662.</mixed-citation><mixed-citation xml:lang="en">Owen A.M., Luan L., Burelbach K.R. et al. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages. Front. Immunol. 2022. 13. 1044661. DOI 10.2289/fimmu.2022.1044662.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ignacio B.J., Albin T.J., Esser-Kahn A.P. et al. Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjugate Chemistry. 2018. 29 (3). 587-603. DOI 10.1021/acs.bioconjchem.7b00808.</mixed-citation><mixed-citation xml:lang="en">Ignacio B.J., Albin T.J., Esser-Kahn A.P. et al. Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjugate Chemistry. 2018. 29 (3). 587-603. DOI 10.1021/acs.bioconjchem.7b00808.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Aluri J., Cooper M.A., Schuettpelz L.G. Toll-Like Receptor Signaling in the Establishment and Function of the Immune System. Cells. 2021. 10 (6). 1374. DOI 10.3390/cells10061374.</mixed-citation><mixed-citation xml:lang="en">Aluri J., Cooper M.A., Schuettpelz L.G. Toll-Like Receptor Signaling in the Establishment and Function of the Immune System. Cells. 2021. 10 (6). 1374. DOI 10.3390/cells10061374.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Murao A., Aziz M., Wang H. et al. Release mechanisms of major DAMPs. Apoptosis. 2021. 26. 152-162. DOI 10.1007/s10495-021-01663-3.</mixed-citation><mixed-citation xml:lang="en">Murao A., Aziz M., Wang H. et al. Release mechanisms of major DAMPs. Apoptosis. 2021. 26. 152-162. DOI 10.1007/s10495-021-01663-3.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Marchi S., Guilbaud E., Tait S.W.G. et al. Mitochondrial control of inflammation. Nat Rev Immunol. 2023. 23. 159-173. DOI 10.1038/s41577-022-00760-x.</mixed-citation><mixed-citation xml:lang="en">Marchi S., Guilbaud E., Tait S.W.G. et al. Mitochondrial control of inflammation. Nat Rev Immunol. 2023. 23. 159-173. DOI 10.1038/s41577-022-00760-x.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Кытикова О.Ю., Денисенко Ю.К., Новгородцева Т.П., Антонюк М.В., Гвозденко Т.А. Свободные жирные кислоты с короткой цепью и их рецепторы в микробиотической концепции развития бронхиальной астмы. Вестник РАМН. 2022. 77 (2). 131-142. DOI 10.15690/vramn1608.</mixed-citation><mixed-citation xml:lang="en">Kytikova O.Yu., Denisenko Yu.K., Novgorodtseva T.P., Antonyuk M.V., Gvozdenko T.A. Short-chain free fatty acids and their receptors in the microbiotic concept of bronchial asthma development. Bulletin of the Russian Academy of Medical Sciences. 2022. 77 (2). 131-142. DOI 10.15690/vramn1608. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lambrecht B.N., Hammad H. The immunology of the allergy epidemic and the hygiene hypothesis. Nat Immunol. 2017.18 (10). 1076-1083. DOI 10.1038/ni.3829.</mixed-citation><mixed-citation xml:lang="en">Lambrecht B.N., Hammad H. The immunology of the allergy epidemic and the hygiene hypothesis. Nat Immunol. 2017.18 (10). 1076-1083. DOI 10.1038/ni.3829. 2</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Papaioannou A.I., Spathis A., Kostikas K. et al. The role of endosomal Toll-like receptors in asthma. Eur. J. Pharmacol. 2017. 808. 14-20. DOI 10.1016/j.ejphar.2016.09.033.</mixed-citation><mixed-citation xml:lang="en">Papaioannou A.I., Spathis A., Kostikas K. et al. The role of endosomal Toll-like receptors in asthma. Eur. J. Pharmacol. 2017. 808. 14-20. DOI 10.1016/j.ejphar.2016.09.033.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hammad H., Lambrecht B.N. The basic immunology of asthma. Cell. 2021. 184 (6). 1469-1485. DOI 10.1016/j.cell.2021.02.016.</mixed-citation><mixed-citation xml:lang="en">Hammad H., Lambrecht B.N. The basic immunology of asthma. Cell. 2021. 184 (6). 1469-1485. DOI 10.1016/j.cell.2021.02.016.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Белоглазов В.А., Лугачев Б.И. Молекулярные механизмы роли Толл-подобных рецепторов 4-го типа и убиквитин-модифицирующего фермента А 20 в патогенезе бронхиальной астмы. Иммунология. 2019. 40 (1). 62-67. DOI 10.24411/0206-4952-2019-11007.</mixed-citation><mixed-citation xml:lang="en">Beloglazov V.A., Lugachev B.I. Molecular mechanisms of the role of Toll-like type 4 receptors and ubiquitin-modifying enzyme A 20 in the pathogenesis of bronchial asthma. Immunology. 2019. 40 (1). 62- 67. DOI 10.24411/0206-4952-2019-11007. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zakeri A., Russo M. Dual role of toll-like receptors in human and experimental asthma models. Front. Immunol. 2018. 9. 1027. DOI 10.3389/fimmu.2018.01027.</mixed-citation><mixed-citation xml:lang="en">Zakeri A., Russo M. Dual role of toll-like receptors in human and experimental asthma models. Front. Immunol. 2018. 9. 1027. DOI 10.3389/fimmu.2018.01027.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Villeneuve C., Kou H.H., Eckermann H. et al. Evolution of the hygiene hypothesis into biota alteration theory: what are the paradigms and where are the clinical applications? Microbes Infect. 2018. 20 (3). 147- 155. DOI 10.1016/j.micinf.2017.11.001.</mixed-citation><mixed-citation xml:lang="en">Villeneuve C., Kou H.H., Eckermann H. et al. Evolution of the hygiene hypothesis into biota alteration theory: what are the paradigms and where are the clinical applications? Microbes Infect. 2018. 20 (3). 147- 155. DOI 10.1016/j.micinf.2017.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nobs S.P., Natali S., Pohlmeier L. et al. PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. J. Exp. Med. 2017. 214 (10). 3015-3035. DOI 10.1084/jem.20162069.</mixed-citation><mixed-citation xml:lang="en">Nobs S.P., Natali S., Pohlmeier L. et al. PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. J. Exp. Med. 2017. 214 (10). 3015-3035. DOI 10.1084/jem.20162069.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Michels K.R., Lukacs N.W., Fonseca W. TLR activation and allergic disease: Early life microbiome and treatment. Curr. Allergy Asthma Rep. 2018. 18 (11). 61. DOI 10.1007/s11882-018-0815-5.</mixed-citation><mixed-citation xml:lang="en">Michels K.R., Lukacs N.W., Fonseca W. TLR activation and allergic disease: Early life microbiome and treatment. Curr. Allergy Asthma Rep. 2018. 18 (11). 61. DOI 10.1007/s11882-018-0815-5.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Conde E., Bertrand R., Balbino B. et al. Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. Nat Commun. 2021. 2574. DOI 10.1038/s41467-021-22834-5.</mixed-citation><mixed-citation xml:lang="en">Conde E., Bertrand R., Balbino B. et al. Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. Nat Commun. 2021. 2574. DOI 10.1038/s41467-021-22834-5.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Terhune T.D., Deth R.C. Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation? International Journal of Environmental Research and Public Health. 2018. 15 (5). 901. DOI 10.3390/ijerph15050901.</mixed-citation><mixed-citation xml:lang="en">Terhune T.D., Deth R.C. Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation? International Journal of Environmental Research and Public Health. 2018. 15 (5). 901. DOI 10.3390/ijerph15050901.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ганковская Л.В., Намазова-Баранова Л.С., Хорева М.В. и др. Особенности экспрессии Tollподобного рецептора 2 и Toll-подобного рецептора 4 у детей с бронхиальной астмой. Медицинская иммунология. 2017. 19 (4). 431-440. DOI 10.15789/15630625-2017-4-431-440.</mixed-citation><mixed-citation xml:lang="en">Gankovskaya L.V., Namazova-Baranova L.S., Khoreva M.V. et al. Features of the expression of Toll-like receptor 2 and Toll-like receptor 4 in children with bronchial asthma. Medical immunology. 2017. 19 (4). 431-440. DOI 10.15789/15630625-2017-4-431-440. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ганковская Л.В., Намазова-Баранова Л.С., Порядин Г.В. и др. Изменение показателей врожденного иммунитета при тяжелой бронхиальной астме у детей. Медицинская иммунология. 2019. 21 (1). 99- 106. DOI 10.15789/1563-0625-2019-1-99-106.</mixed-citation><mixed-citation xml:lang="en">Gankovskaya L.V., Namazova-Baranova L.S., Ordin G.V. et al. Changes in indicators of innate immunity in severe bronchial asthma in children. Medical immunology. 2019. 21 (1). 99-106. DOI 10.15789/1563-0625-2019-1-99-106. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Марковский А.В. Роль некоторых Толл-подобных рецепторов в патогенезе злокачественных новообразований. Забайкальский медицинский вестник. 2018. 3. 120-126.</mixed-citation><mixed-citation xml:lang="en">Markovsky A.V. The role of some Toll-like receptors in the pathogenesis of malignant neoplasms. Zabaikalsky Medical Bulletin. 2018. 3. 120-126. in Russian.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
